SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS

Disclosure: S. Hatoum: None. M. Amiri: None. D. Hopkins: None. R.P. Buyalos: Employee; Self; Fertility & Surgical Associates of California. F. Bril: None. R. Azziz: Advisory Board Member; Self; Arora Forge. Consulting Fee; Self; Rani Therapeutics, Fortress Biotech, Spruce Biosciences, Core Acces...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatoum, Sana, Amiri, Mina, Hopkins, Dawnkimberly, Buyalos, Richard P, Bril, Fernando, Azziz, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554694/
http://dx.doi.org/10.1210/jendso/bvad114.1670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554694/
http://dx.doi.org/10.1210/jendso/bvad114.1670

Ejemplares similares